XIGDUO XR is a combination of 2 drugs: Dapagliflozin and Metformin. It helps significantly lower blood sugar by combining the experience of metformin with a different kind of medicine called an SGLT2 inhibitor. It works by helping to restore body’s proper response to the naturally produced insulin . It also increases the removal of sugar by the kidneys, decreases sugar made in the liver, and thus decreases the sugar body taken in through the stomach and intestines.
Dapagliflozin is indicated to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and established cardiovascular disease (CVD) or multiple cardiovascular (CV) risk factors
XIGDUO XR is indicated as an adjunct, with a proper diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used in people with type 2 diabetes and heart disease to lower the risk of going to the hospital for heart failure.